Article Details
Retrieved on: 2022-03-20 02:18:50
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In order to manufacture the generic version of Pfizer's oral COVID-19 antiviral nirmatrelvir, as many as 19 drugmakers in India have signed ...
Article found on: trak.in
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here